… Keytruda’s dominance in the oncology market, more recent data … the pack in bispecific antibody oncology contenders, ivonescimab isn’t the … $1.25 billion deal with 3SBio for SSG-707, another PD … of the clinic. First, the oncology market has become more segmented …

… Finalizes Global Licensing Agreement with 3sbio, Inc. On July … global licensing agreement with 3SBio, Inc. With this … , manufacture, and commercialize 3SBio’s SSGJ-707, a … 3SBio’s proprietary CLF2 platform, this innovative treatment enhances Pfizer’s oncology …

… with Chinese biotech firm 3SBio, marking the biggest … manufacturing, and commercialization of 3SBio’s promising drug, SSGJ- … and was developed using 3SBio’s proprietary CLF2 platform … prestigious American Society of Clinical Oncology (ASCO) Annual Meeting, …

… with Chinese biotech firm 3SBio, marking the biggest … manufacturing, and commercialization of 3SBio’s promising drug, SSGJ- … and was developed using 3SBio’s proprietary CLF2 platform … prestigious American Society of Clinical Oncology (ASCO) Annual Meeting, …

… 3SBio’s proprietary CLF2 platform. The licensing agreement enhances Pfizer’s oncology … breast cancer, genitourinary cancer, hematology-oncology, and thoracic cancers. Pfizer’s … cancer,” said Johanna Bendell, MD, oncology chief development officer, Pfizer, in …

… with Chinese biopharmaceutical company 3SBio Inc., securing exclusive … , manufacture, and commercialize 3SBio’s experimental cancer therapy, … in expanding Pfizer’s oncology pipeline and reinforces its … and VEGF, developed using 3SBio’s proprietary CLF2 platform …

… China, licensing agreement with 3SBio Inc., which grants Pfizer … manufacturing and commercialization of 3SBio’s SSGJ-707, a … the American Society of Clinical Oncology (ASCO) Annual Meeting. … million equity investment in 3SBio. Additionally, the agreement …

… manufacturing and commercialization of 3SBio’s SSGJ-707, a … million equity investment in 3SBio. Additionally, the agreement provides … here. About Pfizer Oncology At Pfizer Oncology, we are at … agreement between Pfizer and 3SBio, Inc. granting Pfizer exclusive …

… report provide an orientation of oncology dealmaking and business activities. Chapter … licensing deal structure Directory of oncology deal records covering pharmaceutical and … bio 3B Pharmaceuticals 3D Medicines 3SBio 3T Biosciences 4baseCare 4bases 4C …

3Sbio Inc. reported interim phase II … ;A American Society of Clinical Oncology Cancer Respiratory Bispecific antibody Asia …